A Washington State Institute for Public Policy study reveals troubling health consequences for people living near cannabis shops. The September 2025 report found that residents across Washington State who lived close to licensed marijuana retailers proved significantly more likely to develop cannabis use disorder.

The research assessed Medicaid recipients between ages 12 and 64, examining diagnosis rates for cannabis use disorder and related health issues since Washington voters legalised recreational marijuana in 2012.

The Numbers Tell the Story

Researchers compared individuals living within a 10-minute drive of marijuana shops to those residing further away. They used Medicaid claims data spanning 2012 to 2023 to establish diagnosis, hospitalisation, and treatment rates before and after licensed retailers opened.

The findings prove stark. Individuals between ages 12 and 20, below the legal purchase age, showed 13% higher likelihood of receiving a cannabis use disorder diagnosis when living near cannabis shops. Adults aged 21 and older showed a 7% increased risk.

These statistics prove particularly troubling given that young people face heightened vulnerability to developing the disorder. The Centres for Disease Control and Prevention notes that individuals who start using cannabis young or use it regularly face greater risk.

Retail Explosion Across the State

The study period witnessed explosive growth in marijuana retail across Washington State. In 2014, fewer than 50 active retailers operated statewide. By 2023, that number had surged to more than 450 shops.

This dramatic expansion created new health challenges for communities. More retailers meant more exposure, more advertising, and greater normalisation of marijuana use throughout residential areas.

Amani Rashid, a senior research associate with the policy institute, explained that marijuana stores in your neighbourhood increased the chance of receiving a cannabis use disorder diagnosis or experiencing hospitalisation for related issues.

“With more retailers, you have potentially a more competitive market, and with more competitive markets, you potentially have lower prices,” Rashid said. “You might have more advertising in those neighbourhoods. It’s possible retailers will try to differentiate their products more via packaging or different THC concentrations and so on.”

What Cannabis Use Disorder Means

The report describes cannabis use disorder as “characterised by continued use of cannabis despite distress or impairment in one’s life.” The condition proves “robustly tied to depression, anxiety, and other mental health disorders.”

Symptoms include cravings, using marijuana despite it causing personal or professional problems, and being unable to stop using it. The disorder represents more than casual use. It indicates a pattern of dependence that interferes with daily functioning and wellbeing.

Mental Health Consequences Mount

The study assessed how often Medicaid enrollees with cannabis use disorder received diagnoses for mental health issues associated with marijuana use. The impacts extended beyond addiction itself.

Researchers found that those with marijuana stores in your neighbourhood proved more likely to receive an anxiety, depression, bipolar, or psychotic disorder diagnosis for the first time after being diagnosed with cannabis use disorder.

This connection between proximity to retailers and mental health diagnoses raises serious questions about the public health consequences of widespread marijuana commercialisation.

Lawmaker Sounds Alarm

Democratic Washington State Representative Lauren Davis wasn’t surprised by these findings. She represents District 32, which includes Shoreline and Lynnwood. Davis has pushed for stricter regulations on recreational marijuana for years.

“As a result, we have all sorts of products that are of an incredibly high potency,” she said. “We also have pervasive cannabis retail outlets, we also have pervasive advertising and taken together, in aggregate, those have had significant impacts.”

Davis’ proposals have included limiting access to products with high THC concentrations and implementing potency caps. These measures haven’t received widespread support from her colleagues at the state capital.

Still, she believes legislators shouldn’t ignore the public health risks posed by cannabis commercialisation.

Industry Pushes Back

KNKX reached out to the Washington Cannabusiness Association about the policy institute study. The marijuana business trade group’s spokesperson, Aaron Pickus, declined to comment on the report’s findings.

However, Pickus claimed that “it does not appear that the report distinguished between cannabis obtained from legal stores or from the thriving illicit marketplace, which has no guardrails on safety or youth access.”

He also claimed licensed cannabis retailers prove more effective at preventing underage customers from purchasing marijuana than alcohol and tobacco retailers.

This assertion conflicts with the study’s findings that young people aged 12 to 20 living near cannabis shops showed 13% higher rates of cannabis use disorder. The data suggests proximity to legal retailers correlates with increased youth disorder rates.

No Solutions Offered

The report did not provide specific policy recommendations for state officials. Rather, it forms part of an ongoing cost-benefit analysis required by state law to assess the effects of legalising recreational marijuana.

The analysis examines impacts on public health, the economy, and criminal justice. The absence of policy recommendations doesn’t diminish the significance of the findings.

Creating Environments of Use

The Washington State study adds to growing evidence about health risks in communities where marijuana has been legalised. The concentration of retailers in neighbourhoods creates environments where marijuana use becomes normalised and easily accessible.

Lower prices driven by competition, pervasive advertising, and product differentiation through packaging and THC concentrations all contribute to increased use rates. For young people in particular, proximity to retailers correlates strongly with disorder development.

The 13% increased risk for those aged 12 to 20 deserves particular attention. These individuals cannot legally purchase marijuana, yet their proximity to retailers significantly increases their likelihood of developing cannabis use disorder.

This suggests that legal retailers, despite age verification requirements, create an environment that facilitates underage access and use. The mechanisms might include social access through older friends, normalisation that reduces perceived risk, or simply increased availability in the community.

The Mental Health Connection

The link between cannabis use disorder and subsequent mental health diagnoses raises alarm. Individuals who developed cannabis use disorder proved more likely to later receive diagnoses for anxiety, depression, bipolar disorder, or psychotic disorders.

This progression from substance use disorder to additional mental health conditions suggests the public health consequences ripple through communities, affecting mental health systems and family wellbeing.

Questions Policymakers Must Answer

The Washington State findings raise critical questions for jurisdictions considering or implementing marijuana legalisation. How many retailers should communities allow? Should there be minimum distance requirements from schools, parks, or residential areas?

Should states implement potency caps on products sold in retail shops? How can communities protect young people from the normalisation effects of pervasive cannabis retail presence?

Representative Davis’s unsuccessful proposals for stricter regulations suggest political resistance to addressing these health risks. Yet the data demonstrates clear public health consequences of current policies.

The Cost-Benefit Reality

As Washington State continues its legally mandated cost-benefit analysis of marijuana legalisation, the health data from this study provides crucial evidence. The economic benefits of taxation and job creation must be weighed against public health costs.

Cannabis use disorder treatment, mental health services for those developing secondary conditions, and the long-term impacts on young people developing disorders below the legal purchase age all represent costs to communities and healthcare systems.

The evidence documented in this study suggests that proximity matters. Communities cannot simply legalise marijuana and assume that age restrictions and licensing requirements will prevent public health consequences.

The data indicates otherwise. Living near cannabis shops increases the likelihood of developing cannabis use disorder, particularly for young people. Those who develop the disorder face increased risks of additional mental health diagnoses.

These findings demand serious consideration from policymakers, public health officials, and communities grappling with marijuana policy decisions. The health impacts prove real, measurable, and concentrated in neighbourhoods where retailers operate.

Source:OPB